Table 3B.

Parameters at study entry

	N	%
Females/Males	166/176	48.1/51.9
Visible lipohypertrophy	124	35.7
Visible lipoatrophy	18	5.2
Palpable lipohypertrophy	159	45.8
Total lipohypertrophya	169	48.7
5 mm needle used	111	33.3
6 mm needle used	139	41.7
8 mm needle used	79	23.7
12.7 mm needle used	4	1.2
Abdomen used primarily for injections	163	47.0
Thigh used primarily for injections	83	23.9
Buttocks used primarily for injections	14	4.0
Arm used primarily for injections	79	21.8

^aThose with both visible and palpable lipohypertrophy are only counted once.